CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Clinical Trials Arena
Original article

Spinogenix adds Phase IIb autism study to CLARITY basket trial

Phase 2codabakalnerPositive
AI Analysis

Summary

Spinogenix expanded its CLARITY basket trial to include a Phase IIb study of codabakalner in idiopathic autism spectrum disorder (ASD).

Clinical Trial Data

Phase

IIb

Importance:5/10
Sentiment:
0.30
autismASDbasket trialCLARITYclinical trial expansion
Related Companies

Read the original article

Published by Clinical Trials Arena on October 15, 2026 10:03 AM

Read Original